Biomaterials for the treatment of myocardial infarction: a 5-year update.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22152947.
- Also identified by DOI 10.1016/j.jacc.2011.11.001.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The first review on biomaterials for the treatment of myocardial infarction (MI) was written in 2006. In the last 5 years, the general approaches for biomaterial treatment of MI and subsequent left ventricular remodeling remain the same, namely, left ventricular restraints, epicardial patches, and injectable therapies. Nonetheless, there have been significant developments in this field, including advancement of biomaterial therapies to large animal pre-clinical studies and, more recently, to clinical trials. This review focuses on the progress made in the field of cardiac biomaterial treatments for MI over the last 5 years.
Medical subject headings
- Biocompatible Materials
- Myocardial Infarction